Michele A. Glozak
- Molecular Biology top 5%
- Oncology top 5%
- Immunology top 10%
- Cancer Research top 10%
- Hematology top 5%
- Co-authors
- Edward SetoNilanjan SenguptaXiaohong ZhangMelissa B. RogersMaura GasparettoRichard JoveRamadevi NimmanapalliLynn C. Moscinski
- Topics
- Histone Deacetylase Inhibitors Research (5 papers)Cancer-related Molecular Pathways (5 papers)Retinoids in leukemia and cellular processes (4 papers)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Michele A. Glozak
18 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 2.4k
- Oncology 682
- Immunology 257
- Cancer Research 198
- Hematology 188
Countries citing papers authored by Michele A. Glozak
This map shows the geographic impact of Michele A. Glozak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele A. Glozak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele A. Glozak more than expected).
Fields of papers citing papers by Michele A. Glozak
This network shows the impact of papers produced by Michele A. Glozak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele A. Glozak. The network helps show where Michele A. Glozak may publish in the future.
Co-authorship network of co-authors of Michele A. Glozak
This figure shows the co-authorship network connecting the top 25 collaborators of Michele A. Glozak. A scholar is included among the top collaborators of Michele A. Glozak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele A. Glozak. Michele A. Glozak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 95 | |
| 2 | 57 | |
| 3 | 67 | |
| 4 | 19 | |
| 5 | Histone deacetylases and cancerbreakdown → | 836 |
| 6 | 36 | |
| 7 | 15 | |
| 8 | Acetylation and deacetylation of non-histone proteinsbreakdown → | 1303 |
| 9 | 8 | |
| 10 | Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. | 237 |
| 11 | 36 | |
| 12 | 14 | |
| 13 | 18 | |
| 14 | 8 | |
| 15 | 70 | |
| 16 | 8 | |
| 17 | 4 | |
| 18 | 28 |
About Michele A. Glozak
Michele A. Glozak is a scholar working on Molecular Biology, Oncology and Hematology, having authored 18 papers that have together received 2.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Cancer-related Molecular Pathways (5 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Geriatrics and Gerontology (181 citations), Molecular Biology (2.4k citations) and Oncology (682 citations). Michele A. Glozak has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Edward Seto, Nilanjan Sengupta, Xiaohong Zhang, Melissa B. Rogers, Maura Gasparetto, Richard Jove, Ramadevi Nimmanapalli, Lynn C. Moscinski, Jie Wu and Purva Bali. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.